- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01044784
Acute Evaluation of the Safety of Left Ventricular-left Ventricular (LV-LV) Delays and Its Effects on Mechanical Dyssynchrony
July 7, 2020 updated by: Abbott Medical Devices
Acute Evaluation of the Safety of LV-LV Delays and Its Effects on Mechanical Dyssynchrony
The purpose of this study is to evaluate the effects of various LV-LV delays during multi-site left ventricular (MSLV) pacing on mechanical dyssynchrony in cardiac resynchronization therapy (CRT) patients post-implant.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
73
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Bad Rothenfelde, Germany
- Schuchtermannklinik
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients indicated for standard CRT-D indications.
Description
Inclusion Criteria:
- Have an approved indication for a CRT implant
- Undergoing or previously received the implant of a St. Jude Medical Promote Q 3221-36 CRT-D with a Quartet Model 1458Q LV lead at participating clinical study site
- Ability to provide informed consent for study participation and be willing and able to comply with the prescribed evaluations
Exclusion Criteria:
- Have persistent or permanent atrial fibrillation
- Have an intrinsic heart rate of <50 beats per minute
- Have Cheyne-Stokes breathing
- Have undergone cardiac surgery or coronary revascularization procedure within 3 months prior to enrollment or be scheduled for such procedures
- Have had a recent CVA or TIA within 3 months prior to enrollment
- Be less than 18 years of age
- Be pregnant
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Rinaldi CA, Leclercq C, Kranig W, Kacet S, Betts T, Bordachar P, Gutleben KJ, Shetty A, Donal E, Keel A, Ryu K, Farazi TG, Simon M, Naqvi TZ. Improvement in acute contractility and hemodynamics with multipoint pacing via a left ventricular quadripolar pacing lead. J Interv Card Electrophysiol. 2014 Jun;40(1):75-80. doi: 10.1007/s10840-014-9891-1. Epub 2014 Mar 14.
- Rinaldi CA, Kranig W, Leclercq C, Kacet S, Betts T, Bordachar P, Gutleben KJ, Shetty A, Keel A, Ryu K, Farazi TG, Simon M, Naqvi TZ. Acute effects of multisite left ventricular pacing on mechanical dyssynchrony in patients receiving cardiac resynchronization therapy. J Card Fail. 2013 Nov;19(11):731-8. doi: 10.1016/j.cardfail.2013.10.003. Epub 2013 Oct 10. Erratum In: J Card Fail. 2014 May;20(5):376.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2010
Primary Completion (Actual)
March 1, 2012
Study Completion (Actual)
March 1, 2012
Study Registration Dates
First Submitted
January 6, 2010
First Submitted That Met QC Criteria
January 7, 2010
First Posted (Estimate)
January 8, 2010
Study Record Updates
Last Update Posted (Actual)
July 8, 2020
Last Update Submitted That Met QC Criteria
July 7, 2020
Last Verified
July 1, 2020
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 60028011
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiac Resynchronization Therapy
-
Biotronik SE & Co. KGCompletedCardiac Resynchronization Therapy | Pacemaker TherapyGermany, Austria, Spain, Switzerland
-
IRCCS Policlinico S. DonatoRecruiting
-
Monaldi HospitalUnknownCardiac Resynchronization TherapyItaly
-
Hospital Clinic of BarcelonaCompletedCardiac Resynchronization TherapySpain
-
EBR Systems, Inc.Active, not recruitingCardiac Resynchronization TherapyDenmark, Germany, Switzerland
-
Heart and Diabetes Center North-Rhine WestfaliaTerminatedCardiac Resynchronization TherapyGermany
-
StereotaxisTerminatedCardiac Resynchronization TherapyUnited States
-
Abbott Medical DevicesCompleted
-
Boston Scientific CorporationCompletedCardiac Resynchronization TherapyUnited States
-
Azienda Ospedaliera Universitaria Mater Domini,...CompletedCardiac Resynchronization TherapyItaly